Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Locally Advanced Unresectable Breast Carcinoma|Metastatic Breast Carcinoma|Recurrent Breast Carcinoma|Stage IIIB Breast Cancer AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IV Breast Cancer AJCC v6 and v7
Interventions: DRUG: Cyclophosphamide|OTHER: Laboratory Biomarker Analysis|DRUG: Veliparib
Sponsor: National Cancer Institute (NCI)